Goldman Sachs’s Matinas BioPharma MTNB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-35,203
| Closed | -$17.6K | – | 5203 |
|
|
2022
Q4 | $17.6K | Buy |
+35,203
| New | +$17.6K | ﹤0.01% | 4903 |
|
|
2022
Q1 | – | Sell |
-46,457
| Closed | -$47K | – | 5841 |
|
|
2021
Q4 | $47K | Buy |
+46,457
| New | +$47K | ﹤0.01% | 5365 |
|
|
2021
Q2 | – | Sell |
-21,519
| Closed | -$23K | – | 5472 |
|
|
2021
Q1 | $23K | Buy |
+21,519
| New | +$23K | ﹤0.01% | 5196 |
|
|
2020
Q2 | – | Sell |
-243,028
| Closed | -$146K | – | 4488 |
|
|
2020
Q1 | $146K | Buy |
243,028
+155,904
| +179% | +$93.7K | ﹤0.01% | 4050 |
|
|
2019
Q4 | $198K | Buy |
+87,124
| New | +$198K | ﹤0.01% | 3991 |
|
|
2019
Q2 | – | Sell |
-60,389
| Closed | -$66K | – | 4245 |
|
|
2019
Q1 | $66K | Buy |
+60,389
| New | +$66K | ﹤0.01% | 4062 |
|
|
2018
Q4 | – | Sell |
-283,364
| Closed | -$261K | – | 4187 |
|
|
2018
Q3 | $261K | Sell |
283,364
-202,336
| -42% | -$186K | ﹤0.01% | 3719 |
|
|
2018
Q2 | $211K | Buy |
485,700
+470,278
| +3,049% | +$204K | ﹤0.01% | 3866 |
|
|
2018
Q1 | $12K | Sell |
15,422
-39,115
| -72% | -$30.4K | ﹤0.01% | 4164 |
|
|
2017
Q4 | $63K | Buy |
54,537
+34,483
| +172% | +$39.8K | ﹤0.01% | 4021 |
|
|
2017
Q3 | $26K | Buy |
20,054
+9,125
| +83% | +$11.8K | ﹤0.01% | 4176 |
|
|
2017
Q2 | $18K | Sell |
10,929
-210,777
| -95% | -$347K | ﹤0.01% | 4343 |
|
|
2017
Q1 | $614K | Buy |
+221,706
| New | +$614K | ﹤0.01% | 3394 |
|